Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Quest Diagnostics    DGX

QUEST DIAGNOSTICS (DGX)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
02/16/2018 02/20/2018 02/21/2018 02/22/2018 02/23/2018 Date
104.53(c) 102.26(c) 101.91(c) 100.85(c) 102.6(c) Last
782 955 1 108 295 839 062 1 052 237 739 421 Volume
+1.40% -2.17% -0.34% -1.04% +1.74% Change
More quotes
Financials ($)
Sales 2018 7 745 M
EBIT 2018 1 288 M
Net income 2018 799 M
Debt 2018 3 291 M
Yield 2018 1,90%
Sales 2019 7 958 M
EBIT 2019 1 324 M
Net income 2019 836 M
Debt 2019 3 073 M
Yield 2019 2,04%
P/E ratio 2018 17,36
P/E ratio 2019 16,36
EV / Sales2018 2,22x
EV / Sales2019 2,13x
Capitalization 13 890 M
More Financials
Company
Quest Diagnostics, Inc. is engaged in providing diagnostic testing, information and services that help patients, physicians and others to make better healthcare decisions.The company operates through two segments: Diagnostic Information Services and Diagnostic Solutions.The Diagnostic Information... 
More about the company
Surperformance© ratings of Quest Diagnostics
Trading Rating : Investor Rating :
More Ratings
Latest news on QUEST DIAGNOSTICS
02/22QUEST DIAGNOSTICS : To Speak At The Raymond James 39th Annual Institutional Inve..
PR
02/22QUEST DIAGNOSTICS : Leading hair restoration specialists, Stop and Regrow, partn..
AQ
02/22LABORATORY OF AMERICA : National Kidney Foundation, American Society for Clinica..
AQ
02/22QUEST DIAGNOSTICS : Free Research Report as Quest Diagnostics’ Q4 Adjusted EPS G..
AC
02/16AVON PD : Shooting Threat False Alarm, Lockdown Lifted
AQ
02/14PFIZER : EVIO, Inc. adds Top Executives from Pfizer and Quest Diagnostics to Upp..
AQ
02/08QUEST DIAGNOSTICS : New Molecular Diagnostics Study Results Reported from Quest ..
AQ
02/01Quest Diagnostics Completes Acquisition of MedXM
GL
02/01QUEST DIAGNOSTICS : Incorporated to Host Earnings Call
AC
02/01QUEST DIAGNOSTICS INC : Results of Operations and Financial Condition, Financial..
AQ
More news
Sector news : Healthcare Facilities & Services - NEC
02/20FRESENIUS : Helios Expands Two Hospitals in Germany
DJ
01/30HCA HOSPITAL AMERICA : Healtre 4Q Profit Hit by Higher Taxes; Plans Quarterly Di..
DJ
01/22UK stocks decline as gamblers stumble on government clampdown worries
RE
01/07Fresenius CFO backs acquisition course - Boersen-Zeitung
RE
2017FRESENIUS : FMC Expect Positive Impact From U.S. Tax Reform
DJ
More sector news : Healthcare Facilities & Services - NEC
4-Traders Strategies on QUEST DIAGNOSTICS 
QUEST DIAGNOSTICS - 2013
The USD 57.21 support area is tested
BUY
More Strategies
Latest Tweets
02/24Traders Buy Shares of Quest Diagnostics $DGX on Weakness  
02/23$DGX ALERT: New Quest Diagnostics SEC Filing From our Stock News Alerts App 
02/23Quest Diagnostics To Speak At The Raymond James 39th Annual Institutional Inv.. 
02/22“Public opinion is moving in the direction of this bill,” said Jon Cohen, chi..
2
02/22$DGX Quest Diagnostics To Speak At The Raymond James 39th Annual Institutiona.. 
More tweets
Qtime:104
News from SeekingAlpha
02/19THE IM-CAPITAL STRENGTH 20-STOCK UNI : Update February 2018 
02/13Premarket analyst action - healthcare 
02/02Premarket analyst action - healthcare 
02/01Quest Diagnostics' (DGX) CEO Steve Rusckowski on Q4 2017 Results - Earnings C.. 
02/01Quest Diagnostics Q4 top line up 4%; non-GAAP earnings up 4% 
Chart QUEST DIAGNOSTICS
Duration : Period :
Quest Diagnostics Technical Analysis Chart | DGX | US74834L1008 | 4-Traders
Technical analysis trends QUEST DIAGNOSTICS
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 21
Average target price 109 $
Spread / Average Target 6,8%
EPS Revisions
Managers
NameTitle
Stephen H. Rusckowski Chairman, President & Chief Executive Officer
Mark J. Guinan Chief Financial Officer & Senior Vice President
Jay G. Wohlgemuth Chief Medical Officer, SVP-Research & Development
Lidia L. Fonseca Chief Information Officer & Senior Vice President
Gail R. Wilensky Independent Director
Sector and Competitors